Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
10.26 | 41.44 | -75.24% | 0 | 0% |
| P/S |
|
1.93 | 20.2 | -90.44% |
|
|
| P/BV |
|
1.11 | 3.68 | -69.82% |
|
|
| P/FCF |
|
0 | 82.02 | -100% |
|
|
| Ev/Ebitda |
|
20.56 | 16.62 | 23.68% |
|
|
| Ev/S |
|
5.45 | 25.64 | -78.74% |
|
|
| Ev/FCF |
|
0 | 85.08 | -100% |
|
|
| E/P |
|
0.0294 | 0.0217 | 35.61% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
21.22 | 6.32 | 235.64% | 0 | 0% |
| ROE |
|
10.9 | 6.65 | 63.85% |
|
|
| ROA |
|
5.94 | 3.59 | 65.64% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
18.94 | -76.75 | -124.68% |
|
|
| ROCE |
|
0 | 19.43 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.3696 | 0.7406 | -50.09% | 0.3696 | +0% |
| Nеt Debt/Ebitda |
|
0 | -0.1122 | -100% |
|
|
| Debt/Ratio |
|
0 | 0.1008 | -100% |
|
|
| Debt/Equity |
|
0 | 0.212 | -100% |
|
|
| Debt/Net Income |
|
0.4922 | 1.37 | -64.19% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.65/10
|
3.06 | 0.3991 | 666.71% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1 | -100% | ||
| DSI |
|
1 | 0.6935 | 44.2% |
|
|
| Average dividend growth |
|
0 | 3.04 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.4 | -100% |
|
|
| Average percentage for payments |
|
0 | 45.07 | -100% |
|
|
| Difference from average difference in sector |
|
2.66 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
0 | 23.95 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
0 | 12.85 | -100% | ||
| Growth impulse Net Income in 5 years |
|
0 | 62.77 | -100% | ||
| Growth impulse FCF in 5 years |
|
0 | 30.35 | -100% | ||
| Growth impulse EPS in 5 years |
|
0 | 82.9 | -100% |
IP Score
6.17/10
